BRWJX
Price
$25.51
Change
+$0.31 (+1.23%)
Updated
Dec 20 closing price
VIGIX
Price
$214.82
Change
+$2.24 (+1.05%)
Updated
Dec 20 closing price
Ad is loading...

BRWJX vs VIGIX

Header iconBRWJX vs VIGIX Comparison
Open Charts BRWJX vs VIGIXBanner chart's image
MFS Blended Research Growth Eq I
Price$25.51
Change+$0.31 (+1.23%)
VolumeN/A
CapitalizationN/A
Vanguard Growth Index Institutional
Price$214.82
Change+$2.24 (+1.05%)
VolumeN/A
CapitalizationN/A
BRWJX vs VIGIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BRWJX vs. VIGIX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRWJX is a StrongBuy and VIGIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VIGIX has more cash in the bank: 282B vs. BRWJX (398M). BRWJX (0.54) and VIGIX (0.53) have matching dividends . BRWJX was incepted earlier than VIGIX: BRWJX (9 years) vs VIGIX (27 years). BRWJX is a more actively managed with annual turnover of: 64.00 vs. VIGIX (5.00). BRWJX has a lower initial minimum investment than VIGIX: BRWJX (0) vs VIGIX (5000000). VIGIX annual gain was more profitable for investors over the last year : 34.37 vs. BRWJX (31.87). VIGIX return over 5 years is better than : 129.76 vs. BRWJX (72.20).
BRWJXVIGIXBRWJX / VIGIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years27 years-
Gain YTD31.73934.27293%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets398M282B0%
Annual Yield % from dividends0.540.53101%
Returns for 1 year31.8734.3793%
Returns for 3 years30.6732.7794%
Returns for 5 years72.20129.7656%
Returns for 10 yearsN/A298.58-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RCL238.437.67
+3.32%
Royal Caribbean Group
ATUS2.640.08
+3.13%
Altice USA
CCCC3.950.11
+2.73%
C4 Therapeutics
PFSI101.661.56
+1.56%
PennyMac Financial Services
ELEV0.58-0.05
-7.30%
Elevation Oncology